Inventor
Per-Ola Mikael Johansson
Inventor
Huddinge, SE
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds20%
C07KPeptides20%
Y02ATechnologies for adaptation to climate change13%
C07CAcyclic or carbocyclic compounds7%
PatentTitleYear
10,172,846HCV NS-3 serine protease inhibitors20199,856,265'Macrocyclic inhibitors of hepatitis C virus'20189,623,022'Macrocyclic inhibitors of hepatitis C virus'20179,353,103'Macrocyclic inhibitors of hepatitis C virus'20168,754,106'Macrocyclic inhibitors of hepatitis C virus'20148,741,926'Macrocyclic inhibitors of hepatitis C virus'20148,349,869'Macrocylic inhibitors of hepatitis C virus'20137,671,032'HCV NS-3 serine protease inhibitors'20107,608,590'HCV NS-3 serine protease inhibitors'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2019Patents assigned to MEDIVIR AB (9)· patent assignee history
2009–2019Based in Linkoping, SE· patent location history
2013–2014Patents assigned to TIBOTEC PHARM LTD (3)· patent assignee history
2013Patents assigned to BELFRAGE ANNA KARIN GERTRUD LINEA (1)· patent assignee history
2013–2018Based in Huddinge, SE· patent location history
2014Patents assigned to JANSSEN R & D IRELAND (2)· patent assignee history
2016–2018Patents assigned to JANSSEN SCIENCES IRELAND UC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MEDIVIR AB | 9 | 2009–2019 |
| JANSSEN SCIENCES IRELAND UC | 3 | 2016–2018 |
| TIBOTEC PHARM LTD | 3 | 2013–2014 |
| JANSSEN R & D IRELAND | 2 | 2014 |
| BELFRAGE ANNA KARIN GERTRUD LINEA | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Huddinge, SE | 6 | 2013–2018 |
| Linkoping, SE | 3 | 2009–2019 |